Talkiatry and Eating Recovery Center (ERC) and Pathlight Mood & Anxiety Centers (Pathlight) today announced a partnership that eliminates gaps in behavioral health care for children and adults ...
US-based biotechnology company Mind Medicine (MindMed) has dosed the first subject in the 52-week Phase III Voyage study of MM120 orally disintegrating tablets (MM120 ODT) for the treatment of ...
treatment, and how to talk to your doctor. Occasional anxiety is typical and expected. However, when someone experiences chronic or excessive anxiety, they may have an anxiety disorder. Someone may ...
In a comprehensive Genomic Press Interview, Professor Inga Neumann, Chair of the Department of Behavioural and Molecular Neurobiology at the University of Regensburg, reveals groundbreaking insights ...